Article

JOURNAL MENU
Cover
RJAS Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 10 Issue No: 2 eISSN:  pISSN: 2249-2149

Original Article

Effect of Qurs Kafoor in The Management of Usre Tams Ibtedayi (Primary Dysmenorrhoea) - A Clinical Observation

Firdose K F*,1, Begum W2, Shameem I3, Firdose N F4, Lone A5,

1Firdose K F, PG Scholar Dept of Ilmul Qabalat wa Amraze Niswan, NIUM Banglore

2Begum W, Lecturer, Dept. of Ilmul Qabalat wa Amraze Niswan, NIUM, Bangalore

3Shameem I, Lecturers, Dept. of Ilmul Qabalat wa Amraze Niswan, NIUM, Bangalore

4Firdose N F, Physician, H.S Health Care, Banglore.

5Lone A, P.G. Scholar Dept. of Moalijat, NIUM, Banglore

*Corresponding Author:

Firdose K F, PG Scholar Dept of Ilmul Qabalat wa Amraze Niswan, NIUM Banglore, Email:
Received Date: 2012-12-01,
Accepted Date: 2013-01-01,
Published Date: 2013-01-31
Year: 2013, Volume: 3, Issue: 1, Page no. 36-37,
Views: 244, Downloads: 5
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Introduction: Dysmenorrhoea is defined as a severe, painful cramping sensation in the lower abdomen occurring just before or during menstruation. The dysmemrrhoea refers to he pain with no obvious pelvic pathology. It is a common condition. which occurs in 52%, 72% or even 90% of women. It is responsible for he highest degree of absenteeism resulting in loss of work hours and economic loss. The aim of the study is to observe the efficacy of Qurs Kafoor, a compound unani formulations in alleviating Usre Tams ibtedayi( Primary Dysmenorrhoea).

Methodology: Ten patients with regular and painful cycles were observed. USG — pelvis was done to exclude pelvic pathology. Menstrual cramps were rated a four point scale of dysmemrrhoea, from 0 to 3 depending on the severity. Treatment was given a day prior to the expected date of period until pain persists for 2 consecutive cycles. Reduction in four point scale score is the main outcome measure. Results were considered significant with p < 0.05.

Results: Qurs Kafoor showed a significant reduction in four point scale score. In 6 (60%) out of 10 patients four point scale score was reduced to 0, in remaining 4(40%) the  four scale score was reduced to 1. The results were statistically significant

Conclusion : Qurs Kafoor has shown to be effective in the management of primary dysmenorrhoea as assessed by four points scale.

<p><strong>Introduction:</strong> Dysmenorrhoea is defined as a severe, painful cramping sensation in the lower abdomen occurring just before or during menstruation. The dysmemrrhoea refers to he pain with no obvious pelvic pathology. It is a common condition. which occurs in 52%, 72% or even 90% of women. It is responsible for he highest degree of absenteeism resulting in loss of work hours and economic loss. The aim of the study is to observe the efficacy of Qurs Kafoor, a compound unani formulations in alleviating Usre Tams ibtedayi( Primary Dysmenorrhoea).</p> <p><strong> Methodology: </strong>Ten patients with regular and painful cycles were observed. USG &mdash; pelvis was done to exclude pelvic pathology. Menstrual cramps were rated a four point scale of dysmemrrhoea, from 0 to 3 depending on the severity. Treatment was given a day prior to the expected date of period until pain persists for 2 consecutive cycles. Reduction in four point scale score is the main outcome measure. Results were considered significant with p &lt; 0.05.</p> <p><strong>Results:</strong> Qurs Kafoor showed a significant reduction in four point scale score. In 6 (60%) out of 10 patients four point scale score was reduced to 0, in remaining 4(40%) the&nbsp; four scale score was reduced to 1. The results were statistically significant</p> <p><strong>Conclusion : </strong>Qurs Kafoor has shown to be effective in the management of primary dysmenorrhoea as assessed by four points scale.</p>
Keywords
Primary dysmenorrhoea, Qurs Kafoor, Four point scale score
Downloads
  • 1
    FullTextPDF
Article

None

Supporting File
No Pictures
References

None

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.